NEONATAL HEMANGIOMA: CLINICAL EXOME PANEL (Sec. & CNVs) – 3 genes
LabGenetics
Delivery time
3-4 weeks
Sample
Blood
The Neonatal Hemangioma Panel analyzes three genes associated with abnormal blood vessel development in the neonatal period, characterized by benign endothelial proliferation and, in some cases, multiple visceral or vascular complications. Using next-generation sequencing (NGS) with detection of SNVs, indels, and CNVs, it identifies variants in genes involved in angiogenesis, endothelial signaling, and early vascular formation, facilitating genetic diagnosis and differentiation from other congenital vascular syndromes. Genes included: ANTXR1, FLT4, KDR.